Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity--a problem that is no longer restricted to minority groups

S Wiegand, U Maikowski, O Blankenstein… - European journal of …, 2004 - academic.oup.com
Background The incidence of childhood obesity and type 2 diabetes is an increasing
problem in Europe. We determined the prevalence of impaired glucose regulation in a …

[HTML][HTML] Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist

P Kühnen, K Clément, S Wiegand… - … England Journal of …, 2016 - Mass Medical Soc
<p id="p001">Patients with rare defects in the gene encoding proopiomelanocortin (<italic>POMC</italic>)
have extreme early-onset obesity, hyperphagia, hypopigmentation, and …

Cardiovascular risk in 26,008 European overweight children as established by a multicenter database

D I'allemand, S Wiegand, T Reinehr, J Müller… - …, 2008 - Wiley Online Library
Objective: Although the obesity epidemic is progressing in European children too, there is
no consensus on the population‐specific prevalence of comorbidities or efficient diagnostic …

Differences in taste sensitivity between obese and non-obese children and adolescents

…, T Hummel, H Krude, S Wiegand - Archives of disease in …, 2012 - adc.bmj.com
Background Taste sensitivity varies between individuals. Several studies describe differences
between obese and non-obese subjects concerning their taste perception. However, data …

Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16 390 overweight or obese children and adolescents

S Wiegand, KM Keller, M Roebl, T Reinehr… - International journal of …, 2010 - nature.com
Objective: Comorbidities of childhood obesity challenge health-care systems in Europe. Further,
there is a lack of population-specific prevalence data and diagnostic strategies available…

Risk factors and implications of childhood obesity

S Weihrauch-Blüher, S Wiegand - Current obesity reports, 2018 - Springer
Purpose of Review This review summarizes our current understanding of factors associated
with childhood obesity, including latest prevalence rates, effectiveness of intervention …

MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency

…, I Jahnke, S Sharma, J Mokrosinski, S Wiegand… - Nature medicine, 2018 - nature.com
Genetic defects underlying the melanocortin-4 receptor (MC4R) signaling pathway lead to
severe obesity. Three severely obese LEPR-deficient individuals were administered the …

[HTML][HTML] An Alu Element–Associated Hypermethylation Variant of the POMC Gene Is Associated with Childhood Obesity

P Kuehnen, M Mischke, S Wiegand, C Sers… - PLoS …, 2012 - journals.plos.org
The individual risk for common diseases not only depends on genetic but also on epigenetic
polymorphisms. To assess the role of epigenetic variations in the individual risk for obesity, …

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase …

…, K Mai, D Schnabel, S Wiegand… - The lancet Diabetes & …, 2020 - thelancet.com
Background The melanocortin 4 receptor (MC4R), a component of the leptin–melanocortin
pathway, plays a part in bodyweight regulation. Severe early-onset obesity can be caused by …

Current guidelines for obesity prevention in childhood and adolescence

…, J Markert, MJ Müller, A Moss, M Wabitsch, S Wiegand - Obesity facts, 2018 - karger.com
Objective: Current guidelines for prevention of obesity in childhood and adolescence are
discussed. Methods: A literature search was performed in Medline via PubMed, and …